Medicare不会像Zepbound和Wegovy那样覆盖肥胖药品, Medicare won't cover obesity drugs like Zepbound and Wegovy, reversing a Biden proposal.

尽管Joe Biden先前曾提议, 但特朗普政府决定不再覆盖医保处方药覆盖下的Zepbound和Wegovy等昂贵的肥胖性药品, The Trump administration has decided not to cover costly obesity drugs like Zepbound and Wegovy under Medicare's prescription drug coverage, despite a previous proposal by Joe Biden to do so. 医疗保险主要为65岁及65岁以上的人提供服务。 Medicare primarily serves those aged 65 and older. 批评者认为,提供这些药品可以降低长期保健费用,但费用昂贵,每月要花费数百美元。 Critics argue that covering these drugs could reduce long-term health costs, but they can be expensive, costing hundreds per month.